GABA signalling: therapeutic targets for epilepsy, Parkinson’s disease and Huntington’s disease

Author： Kleppner S.R.   Tobin A.J.  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.5, Iss.2, 2001-04, pp. : 219-239

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel therapeutic targets for Huntington’s disease

By Hannan Anthony J  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 639-650

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic strategies in Huntington’s disease

By Alberch Jordi   Canals Josep M   Pérez-Navarro Esther  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 4, 2003-04 ,pp. : 449-465

Informa Healthcare

Access to resources Recommend Favorite

Neuroprotection in Huntington;s Disease

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 2, 2005-03 ,pp. : 143-147

Bentham Science Publishers

Access to resources Recommend Favorite

-Synuclein Ubiquitination and Novel Therapeutic Targets for Parkinson’s Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 4, 2014-06 ,pp. : 630-637

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondria: Prospective Targets for Neuroprotection in Parkinson’s Disease

By  

Current Pharmaceutical Design, Vol. 20, Iss. 35, 2014-10 ,pp. : 5558-5573

Bentham Science Publishers

Access to resources Recommend Favorite